

Amplified Sciences, Inc.
Clinical stage diagnostics company leveraging composition of matter IP with lead assay in pancreatic cancer and 6 months from CLIA regulatory milestone
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location West Lafayette, IN, USA
- Currency USD
- Founded March 2016
- Employees 4
- Incorporation Type C-corp
- Website amplifiedsciences.com
Company Summary
Clinical stage life science in-vitro diagnostics company focused on accurately detecting debilitating diseases sooner with a lead assay for early detection of pancreatic cancer supported by clinical published data. Open $3M Seed round ($1.5M soft circled with 2 VC co-leads) funds opening of clinical lab, CLIA regulatory milestone, commercial launch in 2023, and scales additional assays on their proprietary ultrasensitive chemistry platform.